News

News
Partner news

Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination with Febuxostat

Read full story
Partner news

Metabolex Gout Program Recognized in Windhover's Top 10 Most Interesting Projects to Watch

Read full story
Partner news

Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer

Read full story
Partner news

iScience Interventional Announces Clinical and Commercial Supply Agreement

Read full story
Partner news

GI's Successful Raising Lifts IPO Market Dynamics

Read full story
Partner news

Isconova and Genocea Expand Collaboration

Read full story
Partner news

Johnson & Johnson Invests in Israel's LifeBond

Read full story
Partner news

SuperGen Completes Acquisition of Astex Therapeutics

Read full story
Partner news

Nevro Corp Closes $58 Million in New Financing

Read full story
Partner news

Atlas Genetics Ltd Completes £16.9 million Series B Financing led by Novartis Venture Funds

Read full story
Partner news

Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation

Read full story
Partner news

Five Prime Therapeutics Provides an Update on its Strategic Discovery Collaborations with Pfizer and GlaxoSmithKline

Read full story
Partner news

Spinal Modulation Secures $30 Million Series D Financing

Read full story
Partner news

Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo

Read full story
Partner news

Metabolex Initiates Phase 2 Trial Of Arhalofenate

Read full story